PK time points [Design Issues]

posted by Vaibhav – India, 2022-06-23 21:31 (13 d 20:31 ago) – Posting: # 23077
Views: 195

Dear All,
Are the below sampling points adequate for PK profile?
Median Tmax - 6 days
Mean half life: 26 days
Sub cutaneous: single dose
2, 12 and 24 hrs after administration. Additional samples were collected on day 2, 4, 6, 8, 10, 14, 28, 42, 56, 84, 112 and 140 days.
I have taken these time points from an article available in public domain.
Is there any method to calculate sampling point apart from method mentioned in BABE guidelines?
It’s a difficult to calculate time points for drug who has long Tmax and long half life.
Thank you in advance.


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,192 posts in 4,651 threads, 1,574 registered users;
online 4 (0 registered, 4 guests [including 1 identified bots]).
Forum time: Thursday 18:03 CEST (Europe/Vienna)

Any sufficiently advanced technology
is indistinguishable from magic.    Arthur C. Clarke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5